Registro:

Referencias:

• Tracey, K.J., Cerami, A., Tumor necrosis factor, other cytokines and disease (1993) Annu. Rev. Cell Biol, 9, pp. 317-343
• Vandenabeele, P., Declercg, W., Beyaert, R., Fiers, W., Two tumor necrosis factor receptors: Structure and function (1995) Trends Cell Biol, 5, pp. 392-399
• Tartaglia, L.A., Goeddel, D.V., Two TNF receptors (1992) Immunol. Today, 13, pp. 151-153
• Rothe, M., Wong, S.C., Henzel, W.J., Goeddel, D.V., A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor (1994) Cell, 78, pp. 681-692
• Hsu, H., Xiong, J., Goeddel, D.V., The TNF receptor-1-associated protein TRADD signals cell death and NF-κB activation (1995) Cell, 81, pp. 495-504
• Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., Seed, B., RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death (1995) Cell, 81, pp. 513-523
• Hsu, H., Shu, H.B., Pan, M.G., Goeddel, D.V., TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways (1996) Cell, 84, pp. 299-308
• Hsu, H., Shu, H.B., Baichwall, V., Goeddel, D.V., TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex (1996) Immunity, 4, pp. 387-396
• Liu, Z., Hsu, H., Goeddel, D.V., Karin, M., Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death (1996) Cell, 87, pp. 565-576
• Wajant, H., Henkler, F., Scheurich, P., The TNF-receptor-associated factor family scaffold molecules for cytokine receptors, kinases and their regulators (2001) Cell Signal, 13, pp. 389-400
• Gioacchino, N., Costanzo, A., Guido, F., Moretti, A.B., Burgio, V.L., Agresti, C., Levrero, M., Nuclear factor κB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2 (1998) J. Biol. Chem, 273, pp. 31262-31272
• Beg, A., Baltimore, D., An essential role for NF-κB in preventing TNF-α-induced cell death (1996) Science, 274, pp. 782-784
• Chu, Z.L., McKinsey, T., Liu, L., Gentry, J.J., Malim, M.H., Ballard, D.W., Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 10057-10062
• Wang, C.Y., Mayo, M.W., Baldwin, A.S., TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB (1996) Science, 274, pp. 784-787
• Costas, M.A., Muller Igaz, L., Holsboer, F., Arzt, E., Transrepression of NF-κB is not required for glucocorticoid-mediated protection of TNF-α-induced apoptosis on fibroblasts (2000) Biochim. Biophys. Acta, pp. 122-129. , 1499
• Wang, C., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., Baldwin, A.S., NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation (1998) Science, 281, pp. 1680-1683
• Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., Verma, I.M., Suppression of TNF-α-induced apoptosis by NF-κB (1996) Science, 274, pp. 787-789
• Larrick, J.W., Wright, S.C., Cytotoxic mechanism of tumor necrosis factor-alpha (1990) FASEB J, 4, pp. 3215-3223
• Mukhopadhyay, T., Roth, J.A., Maxwell, S.A., Induction of p53 DNA-binding activity by tumor necrosis factor-α (1996) Int. J. Oncol, 9, pp. 715-720
• Pahl, H.L., Activators and target genes of Rel/NF-κB transcription factors (1999) Oncogene, 18, pp. 6853-6866
• Lin, B., Williams-Skipp, C., Tao, Y., Schleicher, M.S., Cano, L.L., Duke, R.C., Scheinman, R.I., NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type (1999) Cell Death Differ, 6, pp. 570-582
• Cobb, M., Robbins, D., Boulton, T., ERKs, extracellular signal-regulated MAP-2-kinases (1991) Curr. Biol, 3, pp. 1025-1032
• Derijard, B., Hibi, M., Wu, I., Baret, T., Su, B., Deng, T., Karin, M., Davis, R., JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorilates the c-Jun activation domain (1994) Cell, 76, pp. 1025-1037
• Coso, O.A., Chiariello, M., Kalinec, G., Kyriakis, J.M., Woodgett, J., Gutkind, S., Transforming G protein-coupled receptors potently activate JNK (SAPK) (1995) J. Biol. Chem, 270, pp. 5620-5624
• Coso, O., Chiariello, M., Yu, J., Teramoto, H., Crespo, P., Xu, N., Miki, T., Gutkind, J.S., The small GTP-binding proteins Rac and Cdc42 regulate the activity of the JNK (SAPK) signalling pathway (1995) Cell, 81, pp. 1137-1146
• Ono, K., Han, J., The p38 signal transduction pathway activation and function (2000) Cellular Signalling, 12, pp. 1-13
• Nebreda, A.R., Porras, A., P38 MAP kinases: Beyond the stress response (2000) TIBS, 25, pp. 257-260
• Kültz, D., Burg, M., Evolution of osmotic stress and signalling via MAP kinase cascades (1998) J. Exp, 201, pp. 3015-3021
• Bode, J.G., Gatsios, P., Ludwig, S., Rapp, U.R., Häussinger, D., Heinrich, P.C., Graeve, L., The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity (1999) J. Biol. Chem, 274, pp. 30222-30227
• Berghe, W.V., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M.L., Fiers, W., Haegeman, G., P38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor (1998) J. Biol. Chem, 273, pp. 3285-3290
• Downward, J., Ras signaling and apoptosis (1998) Curr. Opin. Genet. Dev, 8, pp. 49-54
• Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P.G., Coso, O.A., Gutkind, J.S., Spiegel, S., Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate (1996) Nature, 381, pp. 800-803
• Monney, L., Olivier, R., Otter, I., Jansen, B., Poirier, G., Borner, C., Role of an acidic compartment in tumor-necrosis-factor-α-induced production of ceramide, activation of caspase-3 and apoptosis (1998) Eur. J. Biochem, 251, pp. 295-303
• Green, D., Apoptopic pathways: The roads to ruin (1998) Cell, 94, pp. 695-698
• Gross, A., McDonnell, J.M., Korsmeyer, S.J., BCL-2 family members and the mitochondria in apoptosis (1999) Genes Dev, 13, pp. 1899-1911
• Gerritsen, M.E., Williams, A.J., Neish, A.S., Moore, N.S., Shi, Y., Collins, T., CREB-binding protein/p300 are transcriptional co-activators of p65 (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 2927-2932
• Bortner, C.D., Hughes, F.M., Cidlowski, J.A., A primary role K+ and Na+ efflux in the activation of apoptosis (1997) J. Biol. Chem, 272, pp. 32436-32442
• Bortner, C.D., Cidlowski, J.A., A necessary role for cell shrinkage in apoptosis (1998) Biochem. Pharmacol, 56, pp. 1549-1559
• Bortner, C.D., Cidlowski, J.A., Volume regulation and ion transport during apoptosis (2000) Methods Enzymol, 322, pp. 421-433
• Okada, Y., Maeno, E., Shimizu, T., Dezaki, K., Wang, J., Morishima, S., Receptor-mediated control of regulatory volume decrease (RVD) and apoptopic volume decrease (AVD) (2001) J. Physiol, 532, pp. 3-16
• Montague, J.W., Bortner, C.D., Hughes, F.M., Cidlowski, J.A., A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis (1999) Steroids, 64, pp. 563-569
• Kültz, D., Madhany, S., Burg, M.B., Hyperosmolality causes growth arrest of murine kidney cells (1998) J. Biol. Chem, 273, pp. 13645-13651
• Carter, A.B., Knudtson, K.L., Monick, M.M., Hunninghake, G.W., The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression (1999) J. Biol. Chem, 274, pp. 30858-30863
• Polla, B.S., Jacquier-Sarlin, M.R., Kantengwa, S., Mariethoz, E., Hennet, T., Russo-Marie, F., Cossarizza, A., TNF alpha alters mitochondrial membrane potential in L929 but not in TNF alpha-resistant L929. 12 cells: Relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity (1996) Free Radic. Res, 25, pp. 125-131
• Albrecht, H., Tschopp, J., Jongeneel, V., Bcl-2 protects from oxidative damage and apoptopic cell death without interferring with activation of NF-κB by TNF (1994) FEBS Letters, 351, pp. 45-48
• Wahl, C., Liptay, S., Adler, G., Schmid, R., Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B (1998) J. Clin. Invest, 101, pp. 1163-1174

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------